<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, 
 <xref rid="B27" ref-type="bibr">Lindesmith et al. (2018)</xref>, reported a strategy of camouflaging antigenic sites to carbohydrate blocking antibodies, named “particle breathing.” Since 1995, many variants causing global epidemics have emerged, including US 1995/96 in 1996 (
 <xref rid="B15" ref-type="bibr">Fankhauser et al., 1998</xref>), Farmington Hills in 2002 (
 <xref rid="B29" ref-type="bibr">Lopman et al., 2004</xref>), Hunter in 2004 (
 <xref rid="B4" ref-type="bibr">Bull et al., 2006</xref>), Den Haag in 2006 (
 <xref rid="B14" ref-type="bibr">Eden et al., 2010</xref>), New Orleans in 2009 (
 <xref rid="B56" ref-type="bibr">Yen et al., 2011</xref>), and Sydney in 2012 (
 <xref rid="B54" ref-type="bibr">van Beek et al., 2013</xref>). However, in 2014, a non-GII.4 genotype, named GII.17_Kawasaki, was reported as the main cause of outbreaks in Asia (
 <xref rid="B30" ref-type="bibr">Lu et al., 2015</xref>; 
 <xref rid="B32" ref-type="bibr">Matsushima et al., 2015</xref>; 
 <xref rid="B50" ref-type="bibr">Thanh et al., 2016</xref>), some countries of the Americas (
 <xref rid="B37" ref-type="bibr">Parra and Green, 2015</xref>; 
 <xref rid="B12" ref-type="bibr">Degiuseppe et al., 2017</xref>; 
 <xref rid="B47" ref-type="bibr">Silva et al., 2017</xref>) and Europe (
 <xref rid="B10" ref-type="bibr">De Graaf et al., 2015</xref>; 
 <xref rid="B18" ref-type="bibr">Giammanco et al., 2017</xref>).
</p>
